New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based...
                   
prnewswire.com     May 16, 2008          

New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma - (Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO ) The Company submitted a supplemental New Drug Application (sNDA) to the U.S.... [read full story]                    


View all news articles about*:
Ambulatory ASCO Cancer Cancers Care Health Hematology Hockey Ice Medical Medicines Millennium NHL Patients Paul Pharmaceuticals Remedies Research Richardson Sports Treatments Winter
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

                   

Patients and Staff Move Out of Princess Royal Hospital and into New Cancer Centre ; A New...

redorbit.com     Aug 26, 2008          

A new pounds70m cancer centre has opened for patients at Castle Hill Hospital in Cottingham. The opening of the pounds70m oncology and haematology centre came after patients and staff relocated from the Princess Royal...                    

comments

Cerebral Infarction: Data on cerebral infarction detailed by researchers at Institute of...

newsrx.com     Aug 26, 2008          

Current study results from the report, 'Potential biomarkers of acute cerebral infarction detected by SELDI-TOF-MS,' have been published. According to recent research from Wuhan, People's Republic of China, "No single...                    

comments

Vion Pharmaceuticals signs agreement with Hovon for Phase III cancer trial

pharmaceutical-business-review.com     Aug 21, 2008   6 related          

Vion Pharmaceuticals has signed an agreement with the Dutch-Belgian Cooperative Trial Group for Hematology Oncology to conduct a clinical trial of laromustine with standard remission-induction therapy in patients aged 18-65...                    

comments

                   

OSU Medical Center Study To Test New Blood-Thinning Drug

emaxhealth.com     28 mins ago          

Researchers here are among scientists nationally evaluating the safety and effectiveness of a treatment created to reduce the incidence of stroke, a debilitating condition suffered by thousands of people each year and the...                    

comments